4.5 Article

Expression Status and Mutational Analysis of the PTEN and PI3K Subunit Genes in Ovarian Granulosa Cell Tumors

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1111/IGC.0b013e3181a1cdfd

关键词

PIK3; PTEN; Ovarian cancer; Granulosa cell tumors

向作者/读者索取更多资源

Granulosa cell tumors (GCT) are a unique subset of ovarian tumors which have a Molecular phenotype resembling that of follicle stimulating hormone (FSH)-stimulated pre-ovulatory granulosa cells. FSH acts via its receptor to stimulate signaling pathways including the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. Activation of this pathway occurs in solid tumors, including ovarian epithelial tumors, through mutation of the PI3K subunit genes or inactivation of the tumor suppressor, PTEN. Activation of this pathway would be predicted to be tumorigenic in granulosa cells. Expression of the 2 PI3K subunit genes, PIK3CA, which encodes the catalytic subunit, and PIK3R1, which encodes the regulatory subunit, together with the PTEN gene was determined in a panel of GCT, 2 human GCT-derived cell lines, COV434 and KGN, and normal ovary. Direct sequence analysis was used to screen for mutations. Expression of all 3 genes was observed in the GCT without evidence of overexpression for the PI3K subunit genes or loss of expression for PTEN. Sequence analysis of amplicons spanning exons 9 and 20, in which greater than 75% of mutations occur in the PIK3CA gene did not identify any missense mutations. Similarly, the previously reported deletions in exons 12 and 13 of the PIK3R1 were not found in the GCT Three amplicons spanning the entire coding sequence of the PTEN gene were sequenced; neither deletions nor mutations were identified. These findings suggest that activation of PI3K signaling through PI3K/PTEN mutation or altered expression, in contrast to many other types of solid tumor, is not associated with GCT.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Medicine, General & Internal

Is it time to screen all patients with hypertension for primary aldosteronism?

Jun Yang, Peter J. Fuller, Michael Stowasser

MEDICAL JOURNAL OF AUSTRALIA (2018)

Article Oncology

Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted TERT Promoter Sequencing

Maria Alexiadis, Simone M. Rowley, Simon Chu, Dilys T. H. Leung, Colin J. R. Stewart, Kaushalya C. Amarasinghe, Ian G. Campbell, Peter J. Fuller

MOLECULAR CANCER RESEARCH (2019)

Article Oncology

Combined PPARγ Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors

Dilys T. H. Leung, Trang Nguyen, Edwina May Oliver, Juliana Matti, Maria Alexiadis, John Silke, Thomas W. Jobling, Peter J. Fuller, Simon Chu

MOLECULAR CANCER THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Cardiomyocyte transcription is controlled by combined mineralocorticoid receptor and circadian clock signalling

Elizabeth K. Fletcher, Monica Kanki, James Morgan, David W. Ray, Lea M. Delbridge, Peter J. Fuller, Colin D. Clyne, Morag J. Young

JOURNAL OF ENDOCRINOLOGY (2019)

Article Multidisciplinary Sciences

Molecular evolution of the switch for progesterone and spironolactone from mineralocorticoid receptor agonist to antagonist

Peter J. Fuller, Yi-Zhou Yao, Ruitao Jin, Sitong He, Beatriz Martin-Fernandez, Morag J. Young, Brian J. Smith

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Endocrinology & Metabolism

Age- and sex-specific reference ranges are needed for the aldosterone/renin ratio

Pravik Solanki, Stella May Gwini, James C. G. Doery, Kay Weng Choy, Jimmy Shen, Morag J. Young, Peter J. Fuller, Jun Yang

CLINICAL ENDOCRINOLOGY (2020)

Review Peripheral Vascular Disease

Primary aldosteronism is a public health issue: challenges and opportunities

Renata Libianto, Peter J. Fuller, Morag J. Young, Jun Yang

JOURNAL OF HUMAN HYPERTENSION (2020)

Review Peripheral Vascular Disease

Structural determinants of activation of the mineralocorticoid receptor: an evolutionary perspective

Peter J. Fuller, Yi-Zhou Yao, Jun Yang, Morag J. Young

Summary: The mineralocorticoid receptor plays a crucial role in sodium homeostasis by responding to aldosterone and cortisol, as well as progesterone with high affinity. The conformation of the receptor is determined by the ligand, which in turn regulates gene expression. Evolutionary studies of the MR suggest novel ways to achieve MR antagonism beyond current progesterone-based antagonists.

JOURNAL OF HUMAN HYPERTENSION (2021)

Review Peripheral Vascular Disease

Identifying new cellular mechanisms of mineralocorticoid receptor activation in the heart

Morag J. Young, Monica Kanki, Peter J. Fuller, Jun Yang

Summary: Recent studies have shown that the mineralocorticoid receptor (MR) plays a crucial role in various tissue types beyond renal epithelial cells, where its actions are mainly defined in the context of pathogenic signaling pathways leading to tissue injury and remodeling. Macrophages and cardiomyocytes are two cell types where the MR is central in the tissue response to factors like injury, renovascular hypertension, and oxidative stress. The dysfunction of MR in these cells contributes to the onset and progression of cardiovascular disease and heart failure.

JOURNAL OF HUMAN HYPERTENSION (2021)

Article Endocrinology & Metabolism

Comparison of ambulatory blood pressure between patients with primary aldosteronism and other forms of hypertension

Renata Libianto, Serena Menezes, Amrina Kaur, Stella May Gwini, Jimmy Shen, Om Narayan, Peter J. Fuller, Jun Yang, Morag J. Young

Summary: Primary aldosteronism (PA) is a potentially curable cause of hypertension with worse cardiovascular prognosis than essential hypertension. This study compared ambulatory blood pressure monitoring (ABPM) parameters in hypertensive patients with and without PA, finding that PA patients had higher blood pressure levels despite similar antihypertensive medication use. ABPM alone may not reliably differentiate PA from other forms of hypertension, and routine biochemical screening remains the most reliable method for detecting PA.

CLINICAL ENDOCRINOLOGY (2021)

Editorial Material Oncology

FOXL2C134W: much ado about something! COMMENT

Peter J. Fuller, Trang Nguyen, Maria Alexiadis, Simon Chu

Summary: Recent studies have suggested that the FOXL2(C134W) mutation is a gain-of-function mutation that enhances interactions with the SMAD transcription factor complex.

JOURNAL OF PATHOLOGY (2022)

Article Endocrinology & Metabolism

Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism

Elisabeth Ng, Stella May Gwini, Renata Libianto, Kay Weng Choy, Zhong X. Lu, Jimmy Shen, James C. G. Doery, Peter J. Fuller, Jun Yang

Summary: This retrospective cohort study investigated the intra-individual variability of plasma aldosterone concentration (PAC), direct renin concentration (DRC), and aldosterone-to-renin ratio (ARR) in patients with and without primary aldosteronism (PA), without interfering medications. The results demonstrated significant variability in PAC, DRC, and ARR, which was higher than the assays' analytical variability. A substantial proportion of PA patients had ARR values below the cut-off for first-line screening. These findings emphasize the need for multiple ARR measurements in the evaluation of PA.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

Glucocorticoids and Water Balance: Implications for Hyponatremia Management and Pituitary Surgery

Mendel Castle-Kirszbaum, Tony Goldschlager, Margaret D. Y. Shi, Peter Fuller

Summary: Water balance is regulated by the hypothalamic pituitary adrenal (HPA) axis, which involves the release of corticotropin releasing hormone (CRH) and cortisol, and their effects on arginine vasopressin (AVP) secretion, as well as the peripheral effects of cortisol on hemodynamics and renal water handling. This review examines the intricate relationship between glucocorticoids and water balance, with emphasis on hyponatremia and pituitary surgery.

NEUROENDOCRINOLOGY (2023)

Article Multidisciplinary Sciences

Poor sleep and shift work associate with increased blood pressure and inflammation in UK Biobank participants

Monica Kanki, Artika P. Nath, Ruidong Xiang, Stephanie Yiallourou, Peter J. Fuller, Timothy J. Cole, Rodrigo Canovas, Morag J. Young

Summary: Disrupted circadian rhythms have been found to be associated with an increased risk of hypertension and cardiovascular disease. This study reveals a U-shaped relationship between sleep length and SBP/DBP, and a positive association between poor sleep quality/night shift work and SBP/DBP.

NATURE COMMUNICATIONS (2023)

Article Medicine, General & Internal

Current pattern of primary aldosteronism diagnosis Delayed and complicated

Yin Yu Lim, Jimmy Shen, Peter J. Fuller, Jun Yang

AUSTRALIAN JOURNAL OF GENERAL PRACTICE (2018)

暂无数据